Association of temozolomide with progressive multifocal leukoencephalopathy: a disproportionality analysis integrated with network pharmacology
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of temozolomide with progressive multifocal leukoencephalopathy: a disproportionality analysis integrated with network pharmacology
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2023-11-02
DOI
10.1080/14740338.2023.2278682
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adverse effects of proton pump inhibitors (PPIs) on the renal system using data mining algorithms (DMAs)
- (2023) Devanshi Jain et al. Expert Opinion On Drug Safety
- Association of antiviral drugs and their possible mechanisms with DRESS syndrome using data mining algorithms
- (2023) Akash Sharma et al. JOURNAL OF MEDICAL VIROLOGY
- Identification of signal of clindamycin associated renal failure acute: A Disproportionality Analysis
- (2023) Anoop Kumar et al. Current Drug Safety
- Identification of novel signal of Raynaud’s phenomenon with Calcitonin Gene-Related Peptide(CGRP) antagonists using data mining algorithms and network pharmacological approaches
- (2023) Rima Singh et al. Expert Opinion On Drug Safety
- Progressive multifocal leukoencephalopathy after first-line radiotherapy and temozolomide for glioblastoma
- (2022) Alberto Picca et al. NEURO-ONCOLOGY
- Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma
- (2022) Emilie Le Rhun et al. NEURO-ONCOLOGY
- Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions
- (2022) Marine Joly et al. BRAIN
- Identification of novel signal of clobazam‐associated drug reaction with eosinophilia and systemic symptoms syndrome: A disproportionality analysis
- (2022) Akash Sharma et al. ACTA NEUROLOGICA SCANDINAVICA
- Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy
- (2021) P. Soma Yasaswi et al. JOURNAL OF CONTROLLED RELEASE
- A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas
- (2021) Lawrence S. Lamb et al. Scientific Reports
- PI3K/AKT/mTOR Signaling Pathway Is Required for JCPyV Infection in Primary Astrocytes
- (2021) Michael P. Wilczek et al. Cells
- Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase
- (2020) Lovisa Sandberg et al. DRUG SAFETY
- Docking Techniques in Toxicology: An overview
- (2019) Meenakshi Gupta et al. Current Bioinformatics
- Docking Techniques in Pharmacology: How Much Promising?
- (2018) Meenakshi Gupta et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies
- (2017) Eric M. L. Williamson et al. Neurotherapeutics
- OpenVigil FDA – Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications
- (2016) Ruwen Böhm et al. PLoS One
- Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea
- (2014) So Hyun Bae et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Progressive multifocal leukoencephalopathy in a patient with glioblastoma
- (2010) Jing Wu et al. JOURNAL OF NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search